Horizon Pharma plc (Nasdaq: HZNP) announced that it has entered into a rebate agreement with Prime Therapeutics, which secures formulary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE